Long-term Safety of Once-daily Hydrocodone Bitartrate (HYD) Tablets For Moderate to Severe Chronic Nonmalignant and Nonneuropathic Pain. Includes a 24-week Extension Period.

Condition: Chronic Nonmalignant and Nonneuropathic PainIntervention: Drug: Hydrocodone bitartrate q24h film-coated tabletsSponsor: Purdue Pharma LPCompleted - verified December 2014

http://clinicaltrials.gov/ct2/show/NCT01400139?lup_s=11%2F25%2F2014&lup_d=30

Source: ClinicalTrials.gov - July 20, 2011 Category: Research Source Type: clinical trials

More News: Chronic Pain | Hydrocodone | Pain | Research